Occudo Quantitative Strategies LP acquired a new stake in Amdocs Limited (NASDAQ:DOX - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 4,628 shares of the technology company's stock, valued at approximately $394,000.
Several other hedge funds and other institutional investors have also made changes to their positions in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Amdocs by 11.6% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 55,076 shares of the technology company's stock valued at $4,689,000 after purchasing an additional 5,713 shares in the last quarter. MJP Associates Inc. ADV acquired a new position in Amdocs in the fourth quarter valued at approximately $527,000. Lazard Asset Management LLC boosted its holdings in Amdocs by 30.9% in the fourth quarter. Lazard Asset Management LLC now owns 12,812 shares of the technology company's stock valued at $1,090,000 after purchasing an additional 3,023 shares in the last quarter. Jefferies Financial Group Inc. acquired a new position in Amdocs in the fourth quarter valued at approximately $1,646,000. Finally, Ethic Inc. boosted its holdings in Amdocs by 54.0% in the fourth quarter. Ethic Inc. now owns 12,739 shares of the technology company's stock valued at $1,085,000 after purchasing an additional 4,466 shares in the last quarter. Hedge funds and other institutional investors own 92.02% of the company's stock.
Amdocs Price Performance
DOX stock opened at $90.68 on Friday. The company has a market capitalization of $10.24 billion, a P/E ratio of 21.04, a PEG ratio of 1.47 and a beta of 0.51. Amdocs Limited has a twelve month low of $74.41 and a twelve month high of $94.61. The business has a 50 day simple moving average of $87.49 and a 200-day simple moving average of $87.08. The company has a current ratio of 1.16, a quick ratio of 1.20 and a debt-to-equity ratio of 0.22.
Amdocs (NASDAQ:DOX - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The technology company reported $1.78 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.07. The business had revenue of $1.13 billion during the quarter, compared to the consensus estimate of $1.12 billion. Amdocs had a return on equity of 18.89% and a net margin of 10.19%. The company's revenue was down 9.4% compared to the same quarter last year. During the same period in the prior year, the company earned $1.56 earnings per share. As a group, equities analysts anticipate that Amdocs Limited will post 6.21 EPS for the current year.
Amdocs Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Monday, June 30th will be paid a dividend of $0.527 per share. This represents a $2.11 annualized dividend and a dividend yield of 2.32%. The ex-dividend date of this dividend is Monday, June 30th. Amdocs's dividend payout ratio (DPR) is presently 44.21%.
Wall Street Analysts Forecast Growth
Separately, StockNews.com downgraded Amdocs from a "strong-buy" rating to a "buy" rating in a report on Friday, February 28th.
View Our Latest Analysis on DOX
About Amdocs
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.